IDEAYA Biosciences (IDYA)

IDEAYA Biosciences (IDYA) Stock Price & Analysis


IDYA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.00 - $24.89
Previous Close$24.87
Average Volume (3M)705.25K
Market Cap
Enterprise Value$1.09B
Total Cash (Recent Filing)$339.47M
Total Debt (Recent Filing)$3.03M
Price to Earnings (P/E)-16.3
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding57,051,300
10 Day Avg. Volume593,703
30 Day Avg. Volume705,246
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)180.06
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue22.94
Enterprise Value/Gross Profit21.37
Enterprise Value/Ebitda-14.68
Price Target Upside31.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was IDEAYA Biosciences’s price range in the past 12 months?
IDEAYA Biosciences lowest stock price was $9.00 and its highest was $24.89 in the past 12 months.
    What is IDEAYA Biosciences’s market cap?
    Currently, no data Available
    When is IDEAYA Biosciences’s upcoming earnings report date?
    IDEAYA Biosciences’s upcoming earnings report date is Aug 14, 2023 which is in 71 days.
      How were IDEAYA Biosciences’s earnings last quarter?
      IDEAYA Biosciences released its earnings results on May 09, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.541 by $0.051.
        Is IDEAYA Biosciences overvalued?
        According to Wall Street analysts IDEAYA Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does IDEAYA Biosciences pay dividends?
          IDEAYA Biosciences does not currently pay dividends.
          What is IDEAYA Biosciences’s EPS estimate?
          IDEAYA Biosciences’s EPS estimate is -$0.55.
            How many shares outstanding does IDEAYA Biosciences have?
            IDEAYA Biosciences has 57,290,176 shares outstanding.
              What happened to IDEAYA Biosciences’s price movement after its last earnings report?
              IDEAYA Biosciences reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.541. Following the earnings report the stock price went up 14.624%.
                Which hedge fund is a major shareholder of IDEAYA Biosciences?
                Among the largest hedge funds holding IDEAYA Biosciences’s share is Deerfield Management Company, LP. It holds IDEAYA Biosciences’s shares valued at 24M.


                  IDEAYA Biosciences Stock Smart Score

                  The IDEAYA Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  IDEAYA Biosciences

                  IDEAYA Biosciences, Inc. develops cancer therapeutics. It is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company operates and manages its business as one operating and reportable segment, which is the business of research and development for oncology-focused precision medicine. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding IDYA

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold IDYA. The ETFs are listed according to market value of IDYA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  RAPT Therapeutics
                  Allogene Therapeutics
                  TScan Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis